{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:13:09Z","timestamp":1787663589108,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7084,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1023\/a:1008363601515","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"965-970","source":"Crossref","is-referenced-by-count":63,"title":["Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients"],"prefix":"10.1016","volume":"11","author":[{"given":"A.","family":"Baars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.E.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.M.","family":"van den Eertwegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.M.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wagstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Vermorken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008363601515_bb0005","series-title":"Cancer: Principles & Practice of Oncology, 5th edition","first-page":"1947","article-title":"Cutaneous Melanoma","author":"Balch","year":"1997"},{"key":"10.1023\/A:1008363601515_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon-\u03b12b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008363601515_bb0015","article-title":"Preliminary analysis of the E1690\/S9111\/C9190 intergroup postoperative aduvant trial of high- and low-dose IFN-\u03b12b (HDI and LDI) in high-risk primary or lymphenode metastatic melanoma","volume":"2072","author":"Kirkwood","year":"1999","journal-title":"ASCO"},{"issue":"5","key":"10.1023\/A:1008363601515_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/ctrv.1999.0138","article-title":"New approaches in the systemic treatment of melanoma","volume":"25","author":"Chowdhury","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"10.1023\/A:1008363601515_bb0025","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and non-cutaneous melanoma: A summary 84.836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1023\/A:1008363601515_bb0030","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.84.9.2911","article-title":"Vaccines containing purified GM2 gangliosides elicit GM2 antibodies in melanoma patients","volume":"84","author":"Livingston","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008363601515_bb0035","first-page":"S22","article-title":"Recombinant interleukin-2-based treatments for advanced melanoma: The experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group","volume":"3","author":"Keilholz","year":"1997","journal-title":"Cancer J Sci Am"},{"key":"10.1023\/A:1008363601515_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0300-2977(96)00083-6","article-title":"The role of adoptive immunotherapy in solid cancers","volume":"50","author":"Kruit","year":"1997","journal-title":"Neth J Med"},{"issue":"2","key":"10.1023\/A:1008363601515_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00008390-199804000-00001","article-title":"The use of interferon-\u03b1 in the treatment of cutaneous melanoma: A review","volume":"8","author":"Punt","year":"1998","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1023\/A:1008363601515_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1072-7515(98)00097-0","article-title":"Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III. randomized, double blind, multicenter vaccinia melanoma oncolysate trial","volume":"187","author":"Wallack","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1023\/A:1008363601515_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","article-title":"Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine","volume":"216","author":"Morton","year":"1992","journal-title":"Ann Surg"},{"key":"10.1023\/A:1008363601515_bb0060","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1200\/JCO.1990.8.11.1858","article-title":"Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients","volume":"8","author":"Berd","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008363601515_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nature Med"},{"issue":"1","key":"10.1023\/A:1008363601515_bb0070","first-page":"111","volume":"8","author":"Dranoff","year":"1997","journal-title":"A phase 1 study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor Hum Gene Ther"},{"key":"10.1023\/A:1008363601515_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vacciantion of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"10.1023\/A:1008363601515_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","article-title":"Active specific immunotherapy for stage II and III human colon cancer: A randomised trial","volume":"353","author":"Vermorken","year":"1999","journal-title":"Lancet"},{"key":"10.1023\/A:1008363601515_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00199194","article-title":"Active specific immunotherapy of residual micrometastasis: an evaluation of sources, doses and ratios of BCG with tumor cells","volume":"7","author":"Hanna","year":"1979","journal-title":"Cancer Immunol Immunother"},{"key":"10.1023\/A:1008363601515_bb0090","first-page":"1353","article-title":"Preparation of immunotherapeutic autologous vaccines from solid tumours","volume":"39","author":"Peters","year":"1979","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008363601515_bb0095","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/jnci\/64.6.1521","article-title":"Active-specific immunotherapy of established micrometastasis: Effect of cryopreservation procedures on tumor cell immunogencity in guinea pigs","volume":"64","author":"Peters","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008363601515_bb0100","first-page":"501","article-title":"Measurement of delayed skin-test responses","volume":"10","author":"Sokal","year":"1975","journal-title":"Nucl J Med"},{"issue":"9","key":"10.1023\/A:1008363601515_bb0105","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.1998.16.9.2913","article-title":"Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine","volume":"16","author":"Hsueh","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008363601515_bb0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.2000.18.1.148","article-title":"Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283","volume":"18","author":"Harris","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1023\/A:1008363601515_bb0115","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1038\/nm0598supp-525","article-title":"Cancer vaccines","volume":"4","author":"Pardoll","year":"1998","journal-title":"Nat Med"},{"key":"10.1023\/A:1008363601515_bb0120","first-page":"4862","volume":"42","author":"Berd","year":"1982","journal-title":"Augmentation of the human immune response by cyclophosphamide Cancer Res"},{"issue":"2","key":"10.1023\/A:1008363601515_bb0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00002371-199903000-00008","article-title":"Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma","volume":"22","author":"Leong","year":"1999","journal-title":"J Immunother"},{"key":"10.1023\/A:1008363601515_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/canjclin.46.4.225","article-title":"Vaccine therapy for malignant melanoma","volume":"46","author":"Morton","year":"1996","journal-title":"CA Cancer J Clin"},{"key":"10.1023\/A:1008363601515_bb0135","series-title":"Medical Oncology A Comprehensive Review","first-page":"363","author":"Pazdur","year":"1993"},{"issue":"12","key":"10.1023\/A:1008363601515_bb0140","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199512000-00006","article-title":"Correlation of tuberculin induration with the number of BCG vaccines","volume":"14","author":"Ildirim","year":"1995","journal-title":"Ped Inf Dis J"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/8\/965\/19478651\/11-8-965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:19:47Z","timestamp":1582165187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341955623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S092375341955623X"],"URL":"https:\/\/doi.org\/10.1023\/a:1008363601515","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}